Tag Archives: mergers

Pharma to Flash the Cash to Counter Bleak Short-Term Outlook

By Julian Upton | Published: July 13, 2011
Nearly two-thirds of US senior pharmaceutical executives surveyed by last month foresee a ‘full economic recovery’ by the end of 2013, with more than half of these pointing to an upturn in the industry’s fortunes by the end of next year. However, 27 percent of the 100 executives interviewed by KPMG for its Industry Pulse Survey [...]
Posted in Strategy | Also tagged , , , | Leave a comment

What Is Behind the Genzyme Job Cuts?

By Julian Upton | Published: September 15, 2010
Troubled biotech Genzyme’s (Cambridge, MA) planned elimination of over 1,000 jobs (10% of its 12,800 workforce, according to the Boston Globe) over the next 15 months is not related to the takeover bid from French giant Sanofi Aventis, the company has said.
Posted in Deals, Global, Strategy | Also tagged , , , , , | Leave a comment

Astellas and OSI Come Together

By Oriana Schwindt | Published: May 19, 2010
The months-long saga is finally over: Astellas’ enhanced offer of $57.50 a share—around $4 billion—has finally netted it Melville, NY-based OSI Pharmaceuticals. The Japan-based pharma first extended an acquisition offer of $52 per share ($3.5 billion) to OSI on March 1, only to be met with a resounding “Nay” from the board, which said $52 [...]
Posted in Deals, News, Strategy | Also tagged , , , , , | Leave a comment

M&A Round-up • 3/25/2009

By George Koroneos | Published: March 25, 2009
The latest round of merger and acquisition activities courtesy of our friends at Pharm Exec Europe: • Just days after its purchase of Genentech, Roche has made another acquisition, albeit a much smaller one, of the German firm Innovatis. Roche will pay EUR 15 million for the cell analytics company. • Oxford Gene Technology (OGT) is to [...]
Posted in Deals | Also tagged , , , , , , , , , | Leave a comment